AD/AD 2020

von muelo | Feb 14, 2020

AD/AD 20202-5Apr2020 in Vienna Learn more Priavoid will participate at the AD/PD in Vienna.Please visit booth: C – 2. News & Events: AD/AD 202014. Februar 2020 BIO.NRW MEDICA-FORUM3. Dezember 2019 DGN Kongress 20192. Oktober 2019 Seed Investment6. Mai 2019 CEOs of...

BIO.NRW MEDICA-FORUM

von Stefanie Simons | Dez 3, 2019

BIO.NRW MEDICA-ForumNovember 18th, 2019 Learn more As part of the BIO.NRW MEDICA-Forum on Monday, 18.11.2019, Prof. Dieter Willbold presented Priavoid’s latest research data during his talk “Do we need anti-prionic compounds to treat Alzheimer’s disease?” News...

DGN Kongress 2019

von Stefanie Simons | Okt 2, 2019

DGN Kongress - StuttgartSeptember 26th, 2019 Learn more Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26th September at 09.10 am.Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved...

Seed Investment

von Dagmar jürgens | Mai 6, 2019

Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with...

CEOs of Priavoid

von Dagmar jürgens | Mai 3, 2019

CEOs of Priavoid 21st February 2019: Dr. Antje Willuweit and Dr. Sabine Willbold became CEOs of Priavoid. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize...